NPPA fixes retail prices of 11 formulations

Download the notification no. S. O. 2742 (E) dt 08-07-2021.

217
NPPA Price of drugs

Last Updated on July 13, 2021 by The Health Master


National Pharmaceutical Pricing Authority
 
(NPPA) has fixed retail prices of eleven (11) formulation under Drugs Prices Control Order (DPCO) – 2013 vide notification no. S. O. 2742 (E) dt 08-07-2021.

DPCO NPPA

These formulations are as under:

Sl. No.Name of the Formulation / Brand NameStrengthUnitManufacturer & Marketing CompanyRetail Price (Rs.)
(1)(2)(3)(4)(5)(6)
1.  Telmisartan + Nebivolol TabletEach uncoated Bilayered Tablet Contains: Telmisartan IP 40 mg Nebivolol Hydrochloride IP Equivalent to Nebivolol 5 mg  1 Tablet  M/s Eris Lifesciences Limited13.61
2.  Glimeperide + Pioglitazone + Metformin HCL (SR) TabletEach uncoated bilayered tablet contains: Glimeperide IP 2mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 1000mg (in sustained release form)  1 Tablet  M/s Windlas Biotech Pvt. Ltd. / M/s Eris Lifesciences Limited12.85
3.  Glimeperide + Pioglitazone + Metformin HCL (SR) TabletEach uncoated bilayered tablet contains: Glimeperide IP 1mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 1000mg (in sustained release form)  1 Tablet  M/s Windlas Biotech Pvt. Ltd. / M/s Eris Lifesciences Limited8.73
4.  Glimeperide + Metformin HCL (SR) TabletEach uncoated tablet contains: Glimeperide IP 2mg Metformin Hydrochloride IP 1000mg (in sustained release form)  1 TabletM/s M/s Agron Remedies Private Limited / M/s Cadila Pharmaceuticals Ltd.9.44
5.  Glimeperide + Metformin HCL (SR) TabletEach uncoated tablet contains: Glimeperide IP 1mg Metformin Hydrochloride IP 1000mg (in sustained release form)  1 TabletM/s M/s Agron Remedies Private Limited / M/s Cadila Pharmaceuticals Ltd.6.86
6.Dextromethorphan Hydrobromide + Chlorpheniramine Meleate SyrupEach 5ml contains: Dextromethorphan Hydrobromide IP 10mg Chlorpheniramine Meleate IP 2mg  1 MLM/s East African (India) Overseas / M/s Cadila Pharmaceuticals Ltd.0.64
7.  Esomeprazole & Domperidone sustained release capsuleEach hard gelatine capsule contains: Esomeprazole Magnesium IP eq. to Esomeprazole 40mg (as enteric coated pellets), Domperidone IP 30mg (as sustained release pellets)  1 Capsul e  M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Jagsonpal Pharmaceuticals Ltd.10.20
8.Telmisartan + Amlodipine + Hydrochlorathiazide TabletEach film coated tablet contains: Telmisartan IP 40mg, Amlodipine Besylate IP eq. to Amlodipine 5mg, Hydrochlorothiazide IP 12.50 mg  1 TabletM/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cadila Pharmaceuticals Ltd.9.56
9.  Nebivolol Hydrochloride + Telmisartan TabletEach uncoated bilayered tablet contains: Nebivolol Hydrochloride IP eq. to Nebivolol 5mg Telmisartan IP 40mg  1 TabletM/s Windlas Biotech limited / M/s Eris Lifesciences Limited13.61
10.  Vitamin D3 Oral DropsEach ml contains: Cholecalciferol (Vitamin D3) IP 800IU  1 MLM/s Akums Drugs & Pharmaceuticals Limited / M/s Cipla Limited5.06
11.Paracetamol + Methocarbamol + Diclofenac Potassium tabletEach Film coated tablet contains: Paracetamol IP 325mg Methocarbamol IP 500mg Diclofenac Potassium BP 50mg tablet  1 TabletM/s Shiv Industries / M/s Profic Organic Limited7.96

The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a Price List in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

As per para 24(4) of DPCO 2013, every retailer and dealer shall display Price List and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.


Latest Notifications: DPCO / NPPA

Latest Notifications: D&C Rules 1945

Latest Notifications: D&C Act 1940


In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

NPPA fixes price of drug for the treatment of Black Fungus

NPPA exempts Torrent Pharma’s this drug from price regulation

NPPA: These three medicines are 50% costlier now

NPPA fixes retail prices of 3 formulations

NPPA fixes retail prices of 12 formulations

NPPA fixes retail prices of 2 formulations

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner